메뉴 건너뛰기




Volumn 31, Issue 51, 2013, Pages 6129-6135

The vaccine candidate BLSOmp31 protects mice against Brucella canis infection

Author keywords

Adjuvants; Brucella canis; Chimera BLSOmp31; Mice; Protection; Vaccine

Indexed keywords

ACELLULAR VACCINE; BRUCELLA VACCINE; CHIMERA BLSOMP31; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 4; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

EID: 84888434325     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.041     Document Type: Article
Times cited : (39)

References (35)
  • 2
    • 77955608716 scopus 로고    scopus 로고
    • Center for Food Security & Public Health in cooperation with the Institute for International Cooperation in Animal Biologics, OIE
    • Canine Brucellosis Brucella canis. Contagious Abortion, Undulant Fever 2007, Center for Food Security & Public Health in cooperation with the Institute for International Cooperation in Animal Biologics, OIE.
    • (2007) Canine Brucellosis Brucella canis. Contagious Abortion, Undulant Fever
  • 4
    • 0141850754 scopus 로고    scopus 로고
    • Canine brucellosis caused by Brucella canis
    • International Veterinary Information Service, L.E. Carmichael (Ed.)
    • Shin S., Carmichael L.E. Canine brucellosis caused by Brucella canis. Recent Advances in Canine Infectious Diseases, 23 November 1999 1999, International Veterinary Information Service. http://www.ivis.org/, L.E. Carmichael (Ed.).
    • (1999) Recent Advances in Canine Infectious Diseases, 23 November 1999
    • Shin, S.1    Carmichael, L.E.2
  • 5
    • 20444499549 scopus 로고    scopus 로고
    • Development of new brucella vaccines by molecular methods
    • Horizon Bioscience, Pamplona, Spain; Norfolk, England, (chapter 17), I. López Goñi, I. Moriyón (Eds.)
    • Hoover D.L., Nikolich M.P., Izadjoo M.J., Borschel R.H., Bhattacharjee A.K. Development of new brucella vaccines by molecular methods. Brucella Molecular and Cellular Biology 2004, Horizon Bioscience, Pamplona, Spain; Norfolk, England, (chapter 17). first ed. I. López Goñi, I. Moriyón (Eds.).
    • (2004) Brucella Molecular and Cellular Biology
    • Hoover, D.L.1    Nikolich, M.P.2    Izadjoo, M.J.3    Borschel, R.H.4    Bhattacharjee, A.K.5
  • 6
    • 0021161578 scopus 로고
    • Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis
    • Carmichael L.E., Zoha S.J., Castro R.F. Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis. Developments in Biological Standardization 1984, 56:371-383.
    • (1984) Developments in Biological Standardization , vol.56 , pp. 371-383
    • Carmichael, L.E.1    Zoha, S.J.2    Castro, R.F.3
  • 9
    • 0345269182 scopus 로고    scopus 로고
    • The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice
    • Estein S.M., Cassataro J., Vizcaíno N., Zygmunt M.S., Cloeckaert A., Bowden R.A. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes and Infection 2003, 5:85-93.
    • (2003) Microbes and Infection , vol.5 , pp. 85-93
    • Estein, S.M.1    Cassataro, J.2    Vizcaíno, N.3    Zygmunt, M.S.4    Cloeckaert, A.5    Bowden, R.A.6
  • 10
  • 11
    • 25444524000 scopus 로고    scopus 로고
    • A DNA vaccine coding for the Brucella Outer Membrane Protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response
    • Cassataro J., Velikovsky A., Barrera Sdl Estein S.M., Bruno L., Bowden R., et al. A DNA vaccine coding for the Brucella Outer Membrane Protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infection and Immunity 2005, 73:6537-6546.
    • (2005) Infection and Immunity , vol.73 , pp. 6537-6546
    • Cassataro, J.1    Velikovsky, A.2    Barrera Sdl Estein, S.M.3    Bruno, L.4    Bowden, R.5
  • 12
    • 35748970465 scopus 로고    scopus 로고
    • Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting
    • Cassataro J., Velikovsky C.A., Bruno L. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clinical and Vaccine Immunology 2007, 14:869-874.
    • (2007) Clinical and Vaccine Immunology , vol.14 , pp. 869-874
    • Cassataro, J.1    Velikovsky, C.A.2    Bruno, L.3
  • 13
    • 0141780959 scopus 로고    scopus 로고
    • Brucella Lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used
    • Velikovsky C.A., Goldbaum F.A., Cassataro J., Estein S.M., Bowden R.A., Bruno L., et al. Brucella Lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infection and Immunity 2003, 71:5750-5755.
    • (2003) Infection and Immunity , vol.71 , pp. 5750-5755
    • Velikovsky, C.A.1    Goldbaum, F.A.2    Cassataro, J.3    Estein, S.M.4    Bowden, R.A.5    Bruno, L.6
  • 16
    • 33744816183 scopus 로고    scopus 로고
    • Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity
    • Rosas G., Fragoso G., Ainciart N., Esquivelguadarrama F., Santana A., Bobes R., et al. Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes and Infection 2006, 8(5):1277-1286.
    • (2006) Microbes and Infection , vol.8 , Issue.5 , pp. 1277-1286
    • Rosas, G.1    Fragoso, G.2    Ainciart, N.3    Esquivelguadarrama, F.4    Santana, A.5    Bobes, R.6
  • 17
    • 34247872947 scopus 로고    scopus 로고
    • A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against Brucella ovis than Rev. 1 vaccination
    • Cassataro J., Pasquevich K.A., Estein S.M., Laplagne D.A., Velikovsky C.A., de la Barrera S., et al. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against Brucella ovis than Rev. 1 vaccination. Vaccine 2007, 25:4437-4446.
    • (2007) Vaccine , vol.25 , pp. 4437-4446
    • Cassataro, J.1    Pasquevich, K.A.2    Estein, S.M.3    Laplagne, D.A.4    Velikovsky, C.A.5    de la Barrera, S.6
  • 18
    • 70350749415 scopus 로고    scopus 로고
    • The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams
    • Estein S.M., Fiorentino M.A., Paolicchi F.A., Clausse M., Manazza J., Cassataro J., et al. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams. Vaccine 2009, 27(48):6704-6711.
    • (2009) Vaccine , vol.27 , Issue.48 , pp. 6704-6711
    • Estein, S.M.1    Fiorentino, M.A.2    Paolicchi, F.A.3    Clausse, M.4    Manazza, J.5    Cassataro, J.6
  • 19
    • 34447532150 scopus 로고    scopus 로고
    • A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against Brucella ovis and a similar degree of protection against B. melitensis than Rev. 1 vaccination
    • Cassataro J., Pasquevich K.A., Estein S.M., Laplagne D.A., Zwerdling A., de la Barrera S., et al. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against Brucella ovis and a similar degree of protection against B. melitensis than Rev. 1 vaccination. Vaccine 2007, 25:5958-5967.
    • (2007) Vaccine , vol.25 , pp. 5958-5967
    • Cassataro, J.1    Pasquevich, K.A.2    Estein, S.M.3    Laplagne, D.A.4    Zwerdling, A.5    de la Barrera, S.6
  • 20
    • 53149116264 scopus 로고    scopus 로고
    • Editorial Médica Panamericana, Buenos Aires, R.A. Margni (Ed.)
    • Inmunología e Inmunoquímica Fundamentos 1996, Editorial Médica Panamericana, Buenos Aires. 5th ed. R.A. Margni (Ed.).
    • (1996) Inmunología e Inmunoquímica Fundamentos
  • 21
    • 84888431723 scopus 로고    scopus 로고
    • Evaluation of a mouse infection model to evaluate homologue and heterologue vaccines against Brucella canis in mouse model
    • (Spanish)
    • Clausse M., Estein S.M. Evaluation of a mouse infection model to evaluate homologue and heterologue vaccines against Brucella canis in mouse model. InVet 2011, 13(2):53-60. (Spanish).
    • (2011) InVet , vol.13 , Issue.2 , pp. 53-60
    • Clausse, M.1    Estein, S.M.2
  • 22
    • 0023210466 scopus 로고
    • A rapid slide agglutination test for the serodiagnosis of Brucella canis infection that employs a variant (M-) organism as antigen
    • Carmichael L.E., Joubert J.C. A rapid slide agglutination test for the serodiagnosis of Brucella canis infection that employs a variant (M-) organism as antigen. Cornell Veterinary 1987, 77:3-12.
    • (1987) Cornell Veterinary , vol.77 , pp. 3-12
    • Carmichael, L.E.1    Joubert, J.C.2
  • 23
    • 0017092788 scopus 로고
    • Transformation normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally
    • Bosseray N., Plommet M. Transformation normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally. Journal of Biological Standardization 1976, 4(4):341-351.
    • (1976) Journal of Biological Standardization , vol.4 , Issue.4 , pp. 341-351
    • Bosseray, N.1    Plommet, M.2
  • 27
    • 84879262014 scopus 로고    scopus 로고
    • Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams
    • Díaz A.G., Clausse M., Paolicchi F.A., Fiorentino M.A., Ghersi G., Zylberman V., et al. Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams. Veterinary Immunology and Immunopathology 2013, 15(154):36-41.
    • (2013) Veterinary Immunology and Immunopathology , vol.15 , Issue.154 , pp. 36-41
    • Díaz, A.G.1    Clausse, M.2    Paolicchi, F.A.3    Fiorentino, M.A.4    Ghersi, G.5    Zylberman, V.6
  • 30
    • 84888439599 scopus 로고    scopus 로고
    • Note for guidance on the use of adjuvanted veterinary vaccines
    • CVMP/IWP/043/97-FINAL Veterinary Medicines Evaluation Unit
    • CVMP/IWP/043/97-FINAL Note for guidance on the use of adjuvanted veterinary vaccines. The European Agency for the Evaluation of Medicinal Products 1998, Veterinary Medicines Evaluation Unit.
    • (1998) The European Agency for the Evaluation of Medicinal Products
  • 32
    • 0031042884 scopus 로고    scopus 로고
    • Adjuvants: a classification and review of their mode of action
    • Cox J.C., Coulter A.R. Adjuvants: a classification and review of their mode of action. Vaccine 1997, 15:248-256.
    • (1997) Vaccine , vol.15 , pp. 248-256
    • Cox, J.C.1    Coulter, A.R.2
  • 33
    • 0027222833 scopus 로고
    • Adjuvants: current status, clinical perspectives and future prospects
    • Audibert A.C., Lise L.D. Adjuvants: current status, clinical perspectives and future prospects. Immunology Today 1993, 14(6):281-284.
    • (1993) Immunology Today , vol.14 , Issue.6 , pp. 281-284
    • Audibert, A.C.1    Lise, L.D.2
  • 34
    • 0028794030 scopus 로고
    • Outer membrane protein and rough lipopolysaccharide specific monoclonal antibodies protect mice against Brucella ovis
    • Bowden R.A., Cloeckaert A., Zygmunt M.S., Bernard S., Dubray G. Outer membrane protein and rough lipopolysaccharide specific monoclonal antibodies protect mice against Brucella ovis. Journal of Medical Microbiology 1995, 43:344-347.
    • (1995) Journal of Medical Microbiology , vol.43 , pp. 344-347
    • Bowden, R.A.1    Cloeckaert, A.2    Zygmunt, M.S.3    Bernard, S.4    Dubray, G.5
  • 35
    • 0028039981 scopus 로고
    • Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines
    • Jiménez De Bagués M.P., Elzer P.H., Blasco J.M., Marin C.M., Gamazo C., Winter A.J. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infection and Immunity 1994, 62:632-638.
    • (1994) Infection and Immunity , vol.62 , pp. 632-638
    • Jiménez De Bagués, M.P.1    Elzer, P.H.2    Blasco, J.M.3    Marin, C.M.4    Gamazo, C.5    Winter, A.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.